OBJECTIVES The aim of this study was to define the morphological features of coronary artery spasm sites using optical coherence tomography (OCT) in patients with vasospastic angina (VSA).
blood stagnation caused by vasospasm could contribute to intimal injury and thrombosis (9) . Although unable to visualize microscopic detail of defects, angioscopic findings have revealed evidence of intimal injury (hemorrhage, flap, thrombus, or ulceration) at the site of coronary artery spasm in patients with VSA (10) . Atherosclerotic plaques at the spasm sites, however, have not been studied extensively. Optical coherence tomography (OCT) is a validated high-resolution imaging modality that has the ability to assess the fibrous cap, thrombus, and lumen irregularity associated with atherosclerotic plaque (11, 12) .
The aim of this study was to evaluate the in vivo morphological characteristics of coronary artery spasm sites using OCT in patients with VSA. We excluded patients who had fixed stenosis ($50% of the lumen diameter) in the spasm site; comorbidities such as congestive heart failure, cardiomyopathy, or chronic kidney disease; or past history of fatal arrhythmias, prior myocardial infarction, or cardiogenic shock. This study was approved by the institutional review board ethics committees at participating centers, and written informed consent was obtained from all participants.
OCT IMAGE ACQUISITION. OCT was performed at the spasm site after administration of 200 mg of intracoronary nitroglycerin, and images were acquired with a commercially available frequency-domain OCT system and optic catheter (C7XR and Dragon 
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Thrombus was defined as a floating or protruding mass into the lumen of a dimension >200 mm and was categorized as either erythrocyte-rich (red) thrombus, defined by high backscattering and high attenuation, or platelet-rich (white) thrombus, defined by homogeneous backscattering with low attenuation (15) . The largest thrombus visualized was measured for area size and maximal and minimal diameter.
Tissue characteristics of underlying plaque were defined by use of previously established criteria (12) . 
Yes No
Observation of optical coherence tomography (OCT) images followed the sequence shown:
identification of plaque at spasm sites, fibrous cap disruption, presence of thrombus, and lumen irregularity.
Shin et al.
OCT OCT FINDINGS. OCT findings are presented in Figure 2 and Table 2 . A representative case of
OCT-defined erosion is demonstrated in Figure 3 . Each panel depicts the specific optical coherence tomography (OCT)-defined characteristics and findings. Values are n (%) or mean AE SD.
OCT ¼ optical coherence tomography; TCFA ¼ thin-cap fibroatheroma.
of lipid plaque used were different between the present study and the previous study of plaque erosion (18) . In the previous study, patients with ACS were selected, and lipid plaque was defined with lipid content in $2 quadrants. In the present study, patients with VSA were included, and even though they had clinical manifestations of ACS, the lipid plaque was defined as lipid content in $1 quadrant. Therefore, more lipid plaque was documented in the present study using this definition. In the present study, we found fibrous cap disruption in 4% of spasm sites, and it was not related to TCFA or cavity in the lipid plaque. Also, non-thin-cap disruption was the main finding of plaque disruption seen in our VSA patients (2 of 3).
Platelet-rich white thrombus was predominantly observed at plaque erosion sites. There was no difference in the incidence and size of thrombus at provoked compared with spontaneous spasm sites.
There was no correlation between thrombus and clinical manifestations in this study. This may be related to the thrombus size, which was relatively small to cause obstruction, and may suggest that the contact of platelets with plaque erosion may not suffice to form large thrombus. It is thought that thrombosis that accompanies vasospasm is a result of grossly reduced blood flow secondary to critical vascular constriction. In an animal study using electron microscopy, a 40% to 60% reduction in luminal diameter of the left anterior descending coronary arteries resulted in endothelial denudation, platelet deposition, and thrombus formation in areas proximal to the point of maximal constriction (19).
The endothelial damage from constriction may result in thrombus formation at the spasm site, followed by partial or total arterial occlusion at that site, especially if superimposed on pre-existing arteriosclerosis. Shin et al.
In another animal study, provoked spasm sites trial, patients with VSA were randomized to receive cilostazol in addition to amlodipine, with significant improvement in angina frequency and intensity (23).
In addition to its vasodilatory properties, cilostazol also has antiplatelet actions that may allow for the prevention of thrombotic complications. Therefore, further research is needed to study this agent's antiplatelet role in VSA patients.
STUDY LIMITATIONS. The findings of the present study are based on a small cohort of patients with angiographic evidence of coronary artery spasm. Also, the proposed definitions using the OCT criteria in this study are for classification of spasm sites in confirmed VSA cases presenting with ACS; therefore, we are unable to broadly generalize this classification as being applicable to all ACS cases. In addition, because OCT was performed only after the spasm provocation test or spontaneous spasm, thrombus might have increased or appeared with the spasm. A further dedicated and larger study to address this possibility is needed.
CONCLUSIONS
Our results show that OCT-defined erosion is a common finding at the site of VSA, with accompanying thrombus present in a substantial proportion of cases.
This finding suggests the potential role for antiplatelet therapy in VSA. 
